Resource Center
Explore Resource Types
Focused Solutions
Biologics
Make advancements with precision biologics tools, designed to enhance your therapeutic approaches encompassing monoclonal antibodies, recombinant proteins, vaccines, and targeted next-generation cell and gene therapies.
Cell and Gene Therapy
The recent success of cell and gene therapies has paved the way for the next generation of advanced therapeutics. While challenges remain, cell and gene therapy research is seeing a transformational shift in the way that novel modalities, such as CAR-T, CRISPR, and vectors, are developed and delivered.
Disease Research
New drug modalities and targets are enabling us to live longer and healthier lives— but their development is grounded on a deep understanding of disease onset and progression.
Drug Development
The process of drug development comprises all the activities involved in bringing a new drug to market once a lead compound has been identified.
Functional Genomic Screening
Identify and characterize drug discovery targets with functional genomic screening services. Offering CRISPR knockout, CRISPR activation, CRISPR inhibition, dual screening and RNAi technologies
Integrated Lab Automation
From cellular screening and imaging applications to high-throughput screening and genomics-based applications, custom explorer™ G3 integrated workstations
Physiological Model Solutions
Drug discovery endeavors require a deep understanding of biological systems and their response to potential therapeutics.
Precision Medicine Research
Countless diseases, especially cancer, are highly heterogenous in nature which means a one-drug-fitsall approach isn’t practical for treating or fighting these diseases effectively.
Small Molecule Drug Discovery
With decades of experience in drug discovery driven by strong customer relationships, Revvity has developed an excellent product portfolio of drug discovery tools for complete solutions serving all parts of the discovery workflow.
All Resources
Filters
817 - 828 of 1187 Results
Guideline for PBMC freezing
CDK signaling in oncology: evaluate phosphorylation events trigged by DNA damage
Development of pharmacokinetic (PK) assays for detecting biosimilars targeting TNF alpha using AlphaLISA
Antigen-stimulated PBMC cytokine release measured by AlphaLISA bovine cytokine kits
Measuring strong to weak binding interactions with AlphaLISA
cAMP assay provides flexibility and stable pharmacology
Biotin-free AlphaLISA assays for the detection of cytokines in PBMC supernatants
Rapid, no-wash measurement of immune checkpoint molecules and cytokines in co-cultures of immune cells and cancer cell lines
Alpha Terbium SureFire Ultra Multiplex: simultaneous dual phosphoprotein target analysis
Screening for inhibitors of PD-1 and PD-L1 binding with AlphaLISA technology
Complementary platforms that enable multiparametric characterization of AAV capsids
Multi-parametric high-throughput analysis of hepatotoxicity using a 3D primary liver cell culture model
Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.